share_log

Flowers Foods, Inc. Just Missed EPS By 7.2%: Here's What Analysts Think Will Happen Next

Flowers Foods, Inc. Just Missed EPS By 7.2%: Here's What Analysts Think Will Happen Next

Flowers Foods, Inc.剛剛下跌了7.2%的每股收益:以下是分析師認爲接下來會發生的事情
Simply Wall St ·  02/24 07:39

Investors in Flowers Foods, Inc. (NYSE:FLO) had a good week, as its shares rose 2.7% to close at US$23.02 following the release of its annual results. Revenues of US$5.1b were in line with forecasts, although statutory earnings per share (EPS) came in below expectations at US$0.58, missing estimates by 7.2%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Flowers Foods after the latest results.

Flowers Foods, Inc.(紐約證券交易所代碼:FLO)的投資者度過了愉快的一週,其股價在公佈年度業績後上漲了2.7%,收於23.02美元。51億美元的收入與預期一致,儘管法定每股收益(EPS)低於預期,爲0.58美元,比預期低7.2%。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。讀者會很高興得知我們已經彙總了最新的法定預測,以了解分析師在最新業績公佈後是否改變了對Flowers Foods的看法。

earnings-and-revenue-growth
NYSE:FLO Earnings and Revenue Growth February 24th 2024
紐約證券交易所:FLO收益和收入增長 2024年2月24日

Following last week's earnings report, Flowers Foods' six analysts are forecasting 2024 revenues to be US$5.16b, approximately in line with the last 12 months. Per-share earnings are expected to leap 112% to US$1.25. In the lead-up to this report, the analysts had been modelling revenues of US$5.16b and earnings per share (EPS) of US$1.26 in 2024. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

繼上週的業績之後,Flowers Foods的六位分析師預測2024年的收入爲51.6億美元,與過去12個月大致持平。每股收益預計將增長112%,至1.25美元。在本報告發布之前,分析師一直在模擬2024年的收入爲51.6億美元,每股收益(EPS)爲1.26美元。鑑於他們的估計沒有重大變化,共識分析師似乎沒有在這些結果中看到任何會改變他們對業務看法的內容。

With no major changes to earnings forecasts, the consensus price target fell 8.9% to US$24.00, suggesting that the analysts might have previously been hoping for an earnings upgrade. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Flowers Foods, with the most bullish analyst valuing it at US$30.00 and the most bearish at US$22.00 per share. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

由於收益預測沒有重大變化,共識目標股價下跌8.9%,至24.00美元,這表明分析師此前可能一直希望收益上調。共識目標股價只是個別分析師目標的平均值,因此——可以很方便地看到基礎估計值的範圍有多廣。對Flowers Foods的看法有所不同,最看漲的分析師將其估值爲30.00美元,最看跌的爲每股22.00美元。這些目標股價表明,分析師對該業務的看法確實有所不同,但這些估計的差異不足以向我們表明,有些人押注取得巨大成功或徹底失敗。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that Flowers Foods' revenue growth is expected to slow, with the forecast 1.4% annualised growth rate until the end of 2024 being well below the historical 4.9% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 2.5% annually. Factoring in the forecast slowdown in growth, it seems obvious that Flowers Foods is also expected to grow slower than other industry participants.

從現在的大局來看,我們可以理解這些預測的方法之一是看看它們如何與過去的業績和行業增長預期相比較。我們要強調的是,Flowers Foods的收入增長預計將放緩,預計到2024年底的年化增長率爲1.4%,遠低於過去五年4.9%的歷史年增長率。相比之下,該行業的其他公司(根據分析師的預測),後者的總體收入預計每年將增長2.5%。考慮到預期的增長放緩,似乎很明顯,預計Flowers Foods的增長速度也將低於其他行業參與者。

The Bottom Line

底線

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Flowers Foods' revenue is expected to perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Flowers Foods' future valuation.

最明顯的結論是,該業務的前景最近沒有重大變化,分析師的收益預測保持穩定,與先前的估計一致。幸運的是,分析師還重申了他們的收入預期,表明收入符合預期。儘管我們的數據確實表明,預計Flowers Foods的收入表現將低於整個行業。共識目標股價大幅下降,最新業績似乎並未讓分析師放心,這導致對Flowers Foods未來估值的估計降低。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Flowers Foods analysts - going out to 2026, and you can see them free on our platform here.

根據這種思路,我們認爲該業務的長期前景比明年的收益重要得多。根據多位Flowers Foods分析師的估計,到2026年,你可以在我們的平台上免費查看。

You still need to take note of risks, for example - Flowers Foods has 4 warning signs we think you should be aware of.

您仍然需要注意風險,例如,Flowers Foods有4個警告信號,我們認爲您應該注意。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論